Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Imaging of Novel Oncologic Treatments in Lung Cancer Part 2: Local Ablative Therapies.

Halpenny D, O'Dwyer E, Camacho Vasquez J, Shaverdian N, Girshman J, Ginsberg MS.

J Thorac Imaging. 2019 Oct 14. doi: 10.1097/RTI.0000000000000452. [Epub ahead of print]

PMID:
31592831
2.

Cardiothoracic manifestations of Erdheim-Chester disease.

Das JP, Xie L, Riedl CC, Hayes SA, Ginsberg MS, Halpenny DF.

Br J Radiol. 2019 Aug 14:20190473. doi: 10.1259/bjr.20190473. [Epub ahead of print]

PMID:
31386554
3.

Clinical significance of perifissural nodules in the oncologic population.

Golia Pernicka JS, Hayes SA, Schor-Bardach R, Sharma R, Zheng J, Moskowitz C, Ginsberg MS.

Clin Imaging. 2019 Sep - Oct;57:110-114. doi: 10.1016/j.clinimag.2019.05.017. Epub 2019 May 31.

PMID:
31207563
4.

Home Environment Factors and Health Behaviors of Low-income, Overweight, and Obese Youth.

Conlon BA, Mcginn AP, Isasi CR, Mossavar-Rahmani Y, Lounsbury DW, Ginsberg MS, Diamantis PM, Groisman-Perelstein AE, Wylie-Rosett J.

Am J Health Behav. 2019 Mar 1;43(2):420-436. doi: 10.5993/AJHB.43.2.17.

PMID:
30808480
5.

Computed tomography features of local pleural recurrence in patients with malignant pleural mesothelioma treated with intensity-modulated pleural radiation therapy.

Halpenny D, Raj M, Rimner A, Zheng J, Capanu M, Ginsberg MS.

Eur Radiol. 2019 Jul;29(7):3696-3704. doi: 10.1007/s00330-018-5937-6. Epub 2019 Jan 28.

PMID:
30689034
6.

Dual-Energy CT Angiography for Detection of Pulmonary Emboli: Incremental Benefit of Iodine Maps.

Weidman EK, Plodkowski AJ, Halpenny DF, Hayes SA, Perez-Johnston R, Zheng J, Moskowitz C, Ginsberg MS.

Radiology. 2018 Nov;289(2):546-553. doi: 10.1148/radiol.2018180594. Epub 2018 Sep 11.

PMID:
30204073
7.

Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial.

Li BT, Shen R, Buonocore D, Olah ZT, Ni A, Ginsberg MS, Ulaner GA, Offin M, Feldman D, Hembrough T, Cecchi F, Schwartz S, Pavlakis N, Clarke S, Won HH, Brzostowski EB, Riely GJ, Solit DB, Hyman DM, Drilon A, Rudin CM, Berger MF, Baselga J, Scaltriti M, Arcila ME, Kris MG.

J Clin Oncol. 2018 Aug 20;36(24):2532-2537. doi: 10.1200/JCO.2018.77.9777. Epub 2018 Jul 10. Erratum in: J Clin Oncol. 2019 Feb 1;37(4):362.

8.

CT features of HER2-mutant lung adenocarcinomas.

Sawan P, Plodkowski AJ, Li AE, Li BT, Drilon A, Capanu M, Ginsberg MS.

Clin Imaging. 2018 Sep - Oct;51:279-283. doi: 10.1016/j.clinimag.2018.05.028. Epub 2018 Jun 7. Review.

9.

Missed Opportunities for HIV Prevention: Individuals Who HIV Seroconverted Despite Accessing Healthcare.

Cossarini F, Hanna DB, Ginsberg MS, Blackstock OJ, Anastos K, Felsen UR.

AIDS Behav. 2018 Nov;22(11):3519-3524. doi: 10.1007/s10461-018-2162-x.

PMID:
29797162
10.

Malignant Pleural Mesothelioma: Are There Imaging Characteristics Associated With Different Histologic Subtypes on Computed Tomography?

Escalon JG, Harrington KA, Plodkowski AJ, Zheng J, Capanu M, Zauderer MG, Rusch VW, Ginsberg MS.

J Comput Assist Tomogr. 2018 Jul/Aug;42(4):601-606. doi: 10.1097/RCT.0000000000000727.

11.

What CT characteristics of lepidic predominant pattern lung adenocarcinomas correlate with invasiveness on pathology?

Aherne EA, Plodkowski AJ, Montecalvo J, Hayan S, Zheng J, Capanu M, Adusumilli PS, Travis WD, Ginsberg MS.

Lung Cancer. 2018 Apr;118:83-89. doi: 10.1016/j.lungcan.2018.01.013. Epub 2018 Feb 3.

12.

Radiographic Predictors of Resectability in Thymic Carcinoma.

Hayes SA, Huang J, Golia Pernicka J, Cunningham J, Zheng J, Moskowitz CS, Ginsberg MS.

Ann Thorac Surg. 2018 Jul;106(1):242-248. doi: 10.1016/j.athoracsur.2018.02.019. Epub 2018 Mar 11.

PMID:
29534953
13.

A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural Mesothelioma.

Zauderer MG, Tsao AS, Dao T, Panageas K, Lai WV, Rimner A, Rusch VW, Adusumilli PS, Ginsberg MS, Gomez D, Rice D, Mehran R, Scheinberg DA, Krug LM.

Clin Cancer Res. 2017 Dec 15;23(24):7483-7489. doi: 10.1158/1078-0432.CCR-17-2169. Epub 2017 Sep 28.

14.

Immunotherapy in Non-Small Cell Lung Cancer Treatment: Current Status and the Role of Imaging.

Carter BW, Halpenny DF, Ginsberg MS, Papadimitrakopoulou VA, de Groot PM.

J Thorac Imaging. 2017 Sep;32(5):300-312. doi: 10.1097/RTI.0000000000000291. Review.

PMID:
28786858
15.

Investigation of patterns of nodal metastases in BRAF mutant lung cancer.

McEvoy SH, Halpenny DF, Viteri-Jusué A, Hayes SA, Plodkowski AJ, Riely GJ, Ginsberg MS.

Lung Cancer. 2017 Jun;108:62-65. doi: 10.1016/j.lungcan.2017.02.024. Epub 2017 Mar 1.

16.

Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies.

Jordan EJ, Kim HR, Arcila ME, Barron D, Chakravarty D, Gao J, Chang MT, Ni A, Kundra R, Jonsson P, Jayakumaran G, Gao SP, Johnsen HC, Hanrahan AJ, Zehir A, Rekhtman N, Ginsberg MS, Li BT, Yu HA, Paik PK, Drilon A, Hellmann MD, Reales DN, Benayed R, Rusch VW, Kris MG, Chaft JE, Baselga J, Taylor BS, Schultz N, Rudin CM, Hyman DM, Berger MF, Solit DB, Ladanyi M, Riely GJ.

Cancer Discov. 2017 Jun;7(6):596-609. doi: 10.1158/2159-8290.CD-16-1337. Epub 2017 Mar 23.

17.

Renal cyst formation in patients treated with crizotinib for non-small cell lung cancer-Incidence, radiological features and clinical characteristics.

Halpenny DF, McEvoy S, Li A, Hayan S, Capanu M, Zheng J, Riely G, Ginsberg MS.

Lung Cancer. 2017 Apr;106:33-36. doi: 10.1016/j.lungcan.2017.01.010. Epub 2017 Jan 22.

18.

Radiogenomic evaluation of lung cancer - Are there imaging characteristics associated with lung adenocarcinomas harboring BRAF mutations?

Halpenny DF, Plodkowski A, Riely G, Zheng J, Litvak A, Moscowitz C, Ginsberg MS.

Clin Imaging. 2017 Mar - Apr;42:147-151. doi: 10.1016/j.clinimag.2016.11.015. Epub 2016 Nov 30.

19.

Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial.

Drilon A, Rekhtman N, Arcila M, Wang L, Ni A, Albano M, Van Voorthuysen M, Somwar R, Smith RS, Montecalvo J, Plodkowski A, Ginsberg MS, Riely GJ, Rudin CM, Ladanyi M, Kris MG.

Lancet Oncol. 2016 Dec;17(12):1653-1660. doi: 10.1016/S1470-2045(16)30562-9. Epub 2016 Nov 4.

20.

Computed Tomographic Appearance of Organizing Pneumonia in an Oncologic Patient Population.

Long NM, Plodkowski AJ, Schor-Bardach R, Geyer AI, Zheng J, Moskowitz CS, Ginsberg MS.

J Comput Assist Tomogr. 2017 May/Jun;41(3):437-441. doi: 10.1097/RCT.0000000000000520.

21.

Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma.

Rimner A, Zauderer MG, Gomez DR, Adusumilli PS, Parhar PK, Wu AJ, Woo KM, Shen R, Ginsberg MS, Yorke ED, Rice DC, Tsao AS, Rosenzweig KE, Rusch VW, Krug LM.

J Clin Oncol. 2016 Aug 10;34(23):2761-8. doi: 10.1200/JCO.2016.67.2675. Epub 2016 Jun 20.

22.

Patients with a Previous History of Malignancy Undergoing Lung Cancer Screening: Clinical Characteristics and Radiologic Findings.

Halpenny DF, Cunningham JD, Long NM, Sosa RE, Ginsberg MS.

J Thorac Oncol. 2016 Sep;11(9):1447-52. doi: 10.1016/j.jtho.2016.05.006. Epub 2016 May 17.

23.

Reply to "Improved postoperative mortality rates after thoracic surgery for lung cancer" [CLM-D-16-00187].

Munden RF, Ginsberg MS.

Clin Imaging. 2016 Jul-Aug;40(4):828-9. doi: 10.1016/j.clinimag.2016.04.016. Epub 2016 Apr 30. No abstract available.

PMID:
27180199
24.

Phase II Study of a Non-Platinum-Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung Adenocarcinomas.

Pietanza MC, Hellmann MD, Fiore JJ, Smith-Marrone S, Basch EM, Schwartz LH, Ginsberg MS, Shouery M, Newman SK, Shaw M, Rogak LJ, Lash AE, Hilden P, Kris MG.

J Thorac Oncol. 2016 Jun;11(6):890-9. doi: 10.1016/j.jtho.2016.02.018. Epub 2016 Mar 8.

25.

Increased Antiretroviral Therapy Use and Virologic Suppression in the Bronx in the Context of Multiple HIV Prevention Strategies.

Hanna DB, Felsen UR, Ginsberg MS, Zingman BS, Beil RS, Futterman DC, Strickler HD, Anastos K.

AIDS Res Hum Retroviruses. 2016 Oct/Nov;32(10-11):955-963. Epub 2016 Mar 17.

26.

Comparison of CT volumetric measurement with RECIST response in patients with lung cancer.

Hayes SA, Pietanza MC, O'Driscoll D, Zheng J, Moskowitz CS, Kris MG, Ginsberg MS.

Eur J Radiol. 2016 Mar;85(3):524-33. doi: 10.1016/j.ejrad.2015.12.019. Epub 2016 Jan 2.

27.

Adaptive Neoadjuvant Chemotherapy Guided by (18)F-FDG PET in Resectable Non-Small Cell Lung Cancers: The NEOSCAN Trial.

Chaft JE, Dunphy M, Naidoo J, Travis WD, Hellmann M, Woo K, Downey R, Rusch V, Ginsberg MS, Azzoli CG, Kris MG.

J Thorac Oncol. 2016 Apr;11(4):537-44. doi: 10.1016/j.jtho.2015.12.104. Epub 2015 Dec 25.

28.

From genotype to phenotype: Are there imaging characteristics associated with lung adenocarcinomas harboring RET and ROS1 rearrangements?

Plodkowski AJ, Drilon A, Halpenny DF, O'Driscoll D, Blair D, Litvak AM, Zheng J, Moskowitz CS, Ginsberg MS.

Lung Cancer. 2015 Nov;90(2):321-5. doi: 10.1016/j.lungcan.2015.09.018. Epub 2015 Sep 21.

29.

Postoperative complications after thoracic surgery for lung cancer.

Rotman JA, Plodkowski AJ, Hayes SA, de Groot PM, Shepard JA, Munden RF, Ginsberg MS.

Clin Imaging. 2015 Sep-Oct;39(5):735-49. doi: 10.1016/j.clinimag.2015.05.013. Epub 2015 Jun 4. Review.

PMID:
26117564
30.

Response to MET inhibitors in patients with stage IV lung adenocarcinomas harboring MET mutations causing exon 14 skipping.

Paik PK, Drilon A, Fan PD, Yu H, Rekhtman N, Ginsberg MS, Borsu L, Schultz N, Berger MF, Rudin CM, Ladanyi M.

Cancer Discov. 2015 Aug;5(8):842-9. doi: 10.1158/2159-8290.CD-14-1467. Epub 2015 May 13. Erratum in: Cancer Discov. 2016 Mar;6(3):330.

31.

Computed tomographic features predictive of local recurrence in patients with early stage lung cancer treated with stereotactic body radiation therapy.

Halpenny D, Ridge CA, Hayes S, Zheng J, Moskowitz CS, Rimner A, Ginsberg MS.

Clin Imaging. 2015 Mar-Apr;39(2):254-8. doi: 10.1016/j.clinimag.2014.12.005. Epub 2014 Dec 12.

32.

Imaging appearances of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia.

Foran PJ, Hayes SA, Blair DJ, Zakowski MF, Ginsberg MS.

Clin Imaging. 2015 Mar-Apr;39(2):243-6. doi: 10.1016/j.clinimag.2014.10.017. Epub 2014 Oct 30.

PMID:
25496668
33.

Are there imaging characteristics associated with lung adenocarcinomas harboring ALK rearrangements?

Halpenny DF, Riely GJ, Hayes S, Yu H, Zheng J, Moskowitz CS, Ginsberg MS.

Lung Cancer. 2014 Nov;86(2):190-4. doi: 10.1016/j.lungcan.2014.09.007. Epub 2014 Sep 17.

34.

Imaging of thoracic cavity tumors.

Hayes SA, Plodkowski AJ, Ginsberg MS.

Surg Oncol Clin N Am. 2014 Oct;23(4):709-33. doi: 10.1016/j.soc.2014.06.005. Epub 2014 Aug 6. Review.

PMID:
25246047
35.

Trial of a 5-day dosing regimen of temozolomide in patients with relapsed small cell lung cancers with assessment of methylguanine-DNA methyltransferase.

Zauderer MG, Drilon A, Kadota K, Huberman K, Sima CS, Bergagnini I, Sumner DK, Travis WD, Heguy A, Ginsberg MS, Holodny AI, Riely GJ, Kris MG, Krug LM, Pietanza MC.

Lung Cancer. 2014 Nov;86(2):237-40. doi: 10.1016/j.lungcan.2014.08.007. Epub 2014 Aug 17.

36.

Clinical consequences of an indeterminate CT pulmonary angiogram in cancer patients.

Hayes SA, Soff GA, Zabor EC, Moskowitz CS, Liu CC, Ginsberg MS.

Clin Imaging. 2014 Sep-Oct;38(5):637-40. doi: 10.1016/j.clinimag.2014.04.015. Epub 2014 May 6.

37.

Preoperative computed tomography findings predict surgical resectability of thymoma.

Hayes SA, Huang J, Plodkowski AJ, Katzen J, Zheng J, Moskowitz CS, Ginsberg MS.

J Thorac Oncol. 2014 Jul;9(7):1023-30. doi: 10.1097/JTO.0000000000000204.

38.

Vinorelbine and gemcitabine as second- or third-line therapy for malignant pleural mesothelioma.

Zauderer MG, Kass SL, Woo K, Sima CS, Ginsberg MS, Krug LM.

Lung Cancer. 2014 Jun;84(3):271-4. doi: 10.1016/j.lungcan.2014.03.006. Epub 2014 Mar 14.

39.

Epidemiology of lung cancer.

Ridge CA, McErlean AM, Ginsberg MS.

Semin Intervent Radiol. 2013 Jun;30(2):93-8. doi: 10.1055/s-0033-1342949. Review.

40.

Comparison of multiplanar reformatted CT lung tumor measurements to axial tumor measurement alone: impact on maximal tumor dimension and T stage.

Ridge CA, Huang J, Cardoza S, Zabor EC, Moskowitz CS, Zakowski MF, Ginsberg MS.

AJR Am J Roentgenol. 2013 Nov;201(5):959-63. doi: 10.2214/AJR.12.10033. Erratum in: AJR Am J Roentgenol. 2014 Jan;202(1):248.

PMID:
24147464
41.

Phase II trial of neoadjuvant bevacizumab plus chemotherapy and adjuvant bevacizumab in patients with resectable nonsquamous non-small-cell lung cancers.

Chaft JE, Rusch V, Ginsberg MS, Paik PK, Finley DJ, Kris MG, Price KA, Azzoli CG, Fury MG, Riely GJ, Krug LM, Downey RJ, Bains MS, Sima CS, Rizk N, Travis WD, Rizvi NA.

J Thorac Oncol. 2013 Aug;8(8):1084-90. doi: 10.1097/JTO.0b013e31829923ec.

42.

Intra- and interobserver variability in CT measurements in oncology.

McErlean A, Panicek DM, Zabor EC, Moskowitz CS, Bitar R, Motzer RJ, Hricak H, Ginsberg MS.

Radiology. 2013 Nov;269(2):451-9. doi: 10.1148/radiol.13122665. Epub 2013 Jul 3.

PMID:
23824993
43.

Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab.

Hellmann MD, Chaft JE, Rusch V, Ginsberg MS, Finley DJ, Kris MG, Price KA, Azzoli CG, Fury MG, Riely GJ, Krug LM, Downey RJ, Bains MS, Sima CS, Rizk N, Travis WD, Rizvi NA, Paik PK.

Cancer Chemother Pharmacol. 2013 Aug;72(2):453-61. doi: 10.1007/s00280-013-2219-5. Epub 2013 Jun 28.

44.

Long-term response to sunitinib therapy for metastatic renal cell carcinoma.

Molina AM, Jia X, Feldman DR, Hsieh JJ, Ginsberg MS, Velasco S, Patil S, Motzer RJ.

Clin Genitourin Cancer. 2013 Sep;11(3):297-302. doi: 10.1016/j.clgc.2013.04.001. Epub 2013 May 24.

45.

Harnessing technology to improve clinical trials: study of real-time informatics to collect data, toxicities, image response assessments, and patient-reported outcomes in a phase II clinical trial.

Pietanza MC, Basch EM, Lash A, Schwartz LH, Ginsberg MS, Zhao B, Shouery M, Shaw M, Rogak LJ, Wilson M, Gabow A, Latif M, Lin KH, Wu Q, Kass SL, Miller CP, Tyson L, Sumner DK, Berkowitz-Hergianto A, Sima CS, Kris MG.

J Clin Oncol. 2013 Jun 1;31(16):2004-9. doi: 10.1200/JCO.2012.45.8117. Epub 2013 Apr 29.

46.

Distinguishing benign thymic lesions from early-stage thymic malignancies on computed tomography.

McErlean A, Huang J, Zabor EC, Moskowitz CS, Ginsberg MS.

J Thorac Oncol. 2013 Jul;8(7):967-73. doi: 10.1097/JTO.0b013e3182904bc2.

47.

Neither FDG-PET Nor CT can distinguish between a pathological complete response and an incomplete response after neoadjuvant chemoradiation in locally advanced rectal cancer: a prospective study.

Guillem JG, Ruby JA, Leibold T, Akhurst TJ, Yeung HW, Gollub MJ, Ginsberg MS, Shia J, Suriawinata AA, Riedel ER, Mazumdar M, Saltz LB, Minsky BD, Nash GM, Paty PB, Temple LK, Weiser MR, Larson SM.

Ann Surg. 2013 Aug;258(2):289-95. doi: 10.1097/SLA.0b013e318277b625.

PMID:
23187748
48.

Advances in oncologic imaging: update on 5 common cancers.

Akin O, Brennan SB, Dershaw DD, Ginsberg MS, Gollub MJ, Schöder H, Panicek DM, Hricak H.

CA Cancer J Clin. 2012 Nov-Dec;62(6):364-93. doi: 10.3322/caac.21156. Epub 2012 Oct 15. Review.

49.

Clinical outcomes with perioperative chemotherapy in sarcomatoid carcinomas of the lung.

Chaft JE, Sima CS, Ginsberg MS, Huang J, Kris MG, Travis WD, Azzoli CG.

J Thorac Oncol. 2012 Sep;7(9):1400-5. doi: 10.1097/JTO.0b013e3182614856.

50.

Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarker.

Pietanza MC, Kadota K, Huberman K, Sima CS, Fiore JJ, Sumner DK, Travis WD, Heguy A, Ginsberg MS, Holodny AI, Chan TA, Rizvi NA, Azzoli CG, Riely GJ, Kris MG, Krug LM.

Clin Cancer Res. 2012 Feb 15;18(4):1138-45. doi: 10.1158/1078-0432.CCR-11-2059. Epub 2012 Jan 6.

Supplemental Content

Loading ...
Support Center